All diseases

Disease Atlas / Disease detail

Clostridioides difficile-associated colitis

Educational material to help understand the causes, symptoms, diagnosis, treatment, and recurrence of Clostridioides difficile-associated colitis.

Clostridium difficile colitis · C. diff colitis · C. diff infection · Clostridioides difficile caused colitis (disease) · Clostridioides difficile colitis (disease) · Clostridium difficile infection · pseudomembranous colitis

MONDO:0000705Public QA completeSource-bound · 5

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 471ecab1c611

Disease category
Clostridioides difficile colitis is an intestinal infection caused by C. difficile or Clostridioides difficile, which can range from diarrhea to more severe colitis.
Core Mechanism
It can occur when C. difficile proliferates after antibiotics reduce the bacteria that prevent infection in the gut, or through contact with contaminated hands, food, or surfaces.
Main Causes and Related Factors
The toxins produced by C. difficile can damage the colonic mucosa and the intestinal environment, causing inflammation and watery diarrhea.
Representative Manifestations
Representative symptoms include watery diarrhea or frequent bowel movements lasting for several days, fever, abdominal pain or abdominal tenderness, loss of appetite, and nausea.
Individual Variability
Advanced age, recent hospital or long-term care facility stays, immunosuppression, antibiotic use, and past infection or exposure can increase risk, but individual risk levels vary.
Diagnosis
Severe diarrhea can cause dehydration, and in some individuals, recurrence may occur within several weeks after infection; in very severe cases, colonic complications may arise.
Management
Diagnosis is made by evaluating symptoms along with recent antibiotic use or exposure to medical institutions, focusing on stool tests, and adding imaging tests if complications are suspected.
Treatment/Research Status
Since it is necessary to distinguish between a carrier state (where bacteria or toxins are detected in stool but no symptoms are present) and an actual infection, severity or the need for treatment cannot be determined by test results alone.
Evidence Reading
Management is conducted within a broad framework that includes re-evaluating the need for continued use of other potentially causative antibiotics, implementing appropriate treatment, fluid replacement, and transmission prevention, and considering hospitalization and complication assessment in severe cases.
Key Points to Note
Treatment may involve antibiotics effective against C. difficile, and surgery may be necessary if there are severe complications or very severe pain.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

Overview

Clostridioides difficile colitis is an intestinal infection caused by C. difficile or Clostridioides difficile, which can range from diarrhea to more severe colitis.

Representative symptoms include watery diarrhea or frequent bowel movements lasting for several days, fever, abdominal pain or abdominal tenderness, loss of appetite, and nausea.

How the Disease Works

It can occur when C. difficile proliferates after antibiotics reduce the bacteria that prevent infection in the gut, or through contact with contaminated hands, food, or surfaces.

The toxins produced by C. difficile can damage the colonic mucosa and the intestinal environment, causing inflammation and watery diarrhea.

Presentation Varies by Individual

Advanced age, recent hospital or long-term care facility stays, immunosuppression, antibiotic use, and past infection or exposure can increase risk, but individual risk levels vary.

The broad framework for diagnosis and management

Severe diarrhea can cause dehydration, and in some individuals, recurrence may occur within several weeks after infection; in very severe cases, colonic complications may arise.

Diagnosis is made by evaluating symptoms along with recent antibiotic use or exposure to medical institutions, focusing on stool tests, and adding imaging tests if complications are suspected.

Current status of treatment

Since it is necessary to distinguish between a carrier state (where bacteria or toxins are detected in stool but no symptoms are present) and an actual infection, severity or the need for treatment cannot be determined by test results alone.

Management is conducted within a broad framework that includes re-evaluating the need for continued use of other potentially causative antibiotics, implementing appropriate treatment, fluid replacement, and transmission prevention, and considering hospitalization and complication assessment in severe cases.

Treatment may involve antibiotics effective against C. difficile, and surgery may be necessary if there are severe complications or very severe pain.

How to interpret clinical trials

After treatment, recurrence of symptoms, dehydration, or abdominal complications should be monitored, and clinical trials should be interpreted by distinguishing between registration status, study status, and whether results are disclosed; the mere existence of a study should not be used to judge its validity.

Key points to verify in clinical consultations

In clinical practice, it is advisable to verify recent antibiotic use and healthcare facility visits, the duration and frequency of diarrhea and presence of bloody stools, signs of fever, abdominal pain, and dehydration, history of recurrence, current medications, the purpose of testing and treatment, and criteria for contact in case of recurrence.

Medical Guidance

This material is for educational purposes only and is not intended as guidance for individual diagnosis or treatment.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.